Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending June 15, 2024 (Week 24) column labels (in same order that data fields appears in each record below): Reporting Area Carbapenemase-Producing Organisms (CPO), Total §; Current week Carbapenemase-Producing Organisms (CPO), Total §; Previous 52 weeks Max + Carbapenemase-Producing Organisms (CPO), Total §; Cum YTD 2024 + Carbapenemase-Producing Organisms (CPO), Total §; Cum YTD 2023 + tab delimited data: U.S. Residents, excluding U.S. Territories 32 NC 1,640 2,496 New England - NC 21 27 Connecticut - NC - - Maine - NC - - Massachusetts - NC - - New Hampshire - NC 7 9 Rhode Island - NC 14 18 Vermont - NC - - Middle Atlantic - NC 59 274 New Jersey - NC - - New York (excluding New York City) - NC - - New York City - NC - 107 Pennsylvania - NC 59 167 East North Central 22 NC 971 753 Illinois - NC - 2 Indiana 2 NC 128 175 Michigan 1 NC 56 127 Ohio 19 NC 787 430 Wisconsin - NC - 19 West North Central - NC 46 70 Iowa - NC 3 34 Kansas - NC 40 34 Minnesota - NC - - Missouri - NC - - Nebraska - NC - - North Dakota - NC - 2 South Dakota - NC 3 - South Atlantic 4 NC 86 364 Delaware - NC - 4 District of Columbia - NC - - Florida N NC N N Georgia - NC - 135 Maryland - NC - - North Carolina - NC - 78 South Carolina - NC - - Virginia 4 NC 35 113 West Virginia - NC 51 34 East South Central - NC - 70 Alabama N NC N N Kentucky - NC - - Mississippi - NC - 70 Tennessee - NC - - West South Central - NC - 8 Arkansas - NC - - Louisiana - NC - 8 Oklahoma - NC - - Texas - NC - - Mountain 6 NC 447 367 Arizona 6 NC 434 352 Colorado - NC - - Idaho - NC - - Montana - NC 4 1 Nevada - NC 1 5 New Mexico - NC - - Utah - NC 8 8 Wyoming - NC - 1 Pacific - NC 10 563 Alaska - NC - - California - NC - 546 Hawaii - NC - 5 Oregon - NC 10 6 Washington - NC - 6 U.S. Territories - NC - 20 American Samoa - NC - - Commonwealth of Northern Mariana Islands - NC - - Guam - NC - - Puerto Rico - NC - 20 U.S. Virgin Islands - NC - - Non-U.S. Residents - NC - - Total 32 NC 1,640 2,516 U: Unavailable - The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data. -: No reported cases - The reporting jurisdiction did not submit any cases to CDC. N: Not reportable - The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction. NN: Not nationally notifiable - This condition was not designated as being nationally notifiable. NP: Nationally notifiable but not published. NC: Not calculated - There is insufficient data available to support the calculation of this statistic. Cum: Cumulative year-to-date counts. * Case counts for reporting years 2023 and 2024 are provisional and subject to change. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/ § Beginning in January 2023, cases began to be reported as Carbapenemase-Producing Organisms, clinical or Carbapenemase-Producing Organisms, screening. In previous years, only Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) cases were reported.